Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shernan G Holtan

Showing results (11-20 of 150) with videos related to

Pageof 15
Sort By:
Infectious Disease Clinics of North America|April 4, 2019
Host and Graft Factors Impacting Infection Risk in Hematopoietic Cell TransplantationRoy L Kao, Shernan G Holtan
Blood|June 11, 2014
Acute graft-versus-host disease: a bench-to-bedside updateShernan G Holtan, Marcelo Pasquini, Daniel J Weisdorf
Best Practice & Research. Clinical Haematology|December 13, 2023
The best GVHD prophylaxis: Or at least progress towards finding itDaniel Weisdorf, Najla El Jurdi, Shernan G Holtan
Case Reports in Transplantation|December 7, 2018
Life-Threatening Hypertriglyceridemia in a Patient on Ruxolitinib and Sirolimus for Chronic Graft-versus-Host DiseaseAllison P Watson, Claudio G Brunstein, Shernan G Holtan
Mayo Clinic Proceedings|November 3, 2009
Cancer and pregnancy: parallels in growth, invasion, and immune modulation and implications for cancer therapeutic agentsShernan G Holtan, Douglas J Creedon, Paul Haluska, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2021
Optimizing Donor Choice and GVHD Prophylaxis in Allogeneic Hematopoietic Cell TransplantationShernan G Holtan, Jurjen Versluis, Daniel J Weisdorf, et al.
Mayo Clinic Proceedings|August 4, 2007
Diagnosis of obesity by primary care physicians and impact on obesity managementAditya Bardia, Shernan G Holtan, Jeffrey M Slezak, et al.
Placenta|June 1, 2025
Placental growth factor enhances inflammatory toll-like receptor responses in syncytiotrophoblastsLaura F Newell, Shernan G Holtan, Leena Kadam, et al.
American Journal of Hematology|July 31, 2018
Antibiotic practice patterns in hematopoietic cell transplantation: A survey of blood and marrow transplant clinical trials network centersArmin Rashidi, Tamna Wangjam, Ami S Bhatt, et al.
Frontiers in Immunology|September 18, 2015
Immune Reactivation by Cell-Free Fetal DNA in Healthy Pregnancies Re-Purposed to Target Tumors: Novel Checkpoint Inhibition in Cancer TherapeuticsElizabeth Ann L Enninga, Wendy K Nevala, Shernan G Holtan, et al.
Pageof 15

Showing results (11-20 of 150) with videos related to

Sort By:
Pageof 15
Infectious Disease Clinics of North America|April 4, 2019
Host and Graft Factors Impacting Infection Risk in Hematopoietic Cell TransplantationRoy L Kao, Shernan G Holtan
Blood|June 11, 2014
Acute graft-versus-host disease: a bench-to-bedside updateShernan G Holtan, Marcelo Pasquini, Daniel J Weisdorf
Best Practice & Research. Clinical Haematology|December 13, 2023
The best GVHD prophylaxis: Or at least progress towards finding itDaniel Weisdorf, Najla El Jurdi, Shernan G Holtan
Case Reports in Transplantation|December 7, 2018
Life-Threatening Hypertriglyceridemia in a Patient on Ruxolitinib and Sirolimus for Chronic Graft-versus-Host DiseaseAllison P Watson, Claudio G Brunstein, Shernan G Holtan
Mayo Clinic Proceedings|November 3, 2009
Cancer and pregnancy: parallels in growth, invasion, and immune modulation and implications for cancer therapeutic agentsShernan G Holtan, Douglas J Creedon, Paul Haluska, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2021
Optimizing Donor Choice and GVHD Prophylaxis in Allogeneic Hematopoietic Cell TransplantationShernan G Holtan, Jurjen Versluis, Daniel J Weisdorf, et al.
Mayo Clinic Proceedings|August 4, 2007
Diagnosis of obesity by primary care physicians and impact on obesity managementAditya Bardia, Shernan G Holtan, Jeffrey M Slezak, et al.
Placenta|June 1, 2025
Placental growth factor enhances inflammatory toll-like receptor responses in syncytiotrophoblastsLaura F Newell, Shernan G Holtan, Leena Kadam, et al.
American Journal of Hematology|July 31, 2018
Antibiotic practice patterns in hematopoietic cell transplantation: A survey of blood and marrow transplant clinical trials network centersArmin Rashidi, Tamna Wangjam, Ami S Bhatt, et al.
Frontiers in Immunology|September 18, 2015
Immune Reactivation by Cell-Free Fetal DNA in Healthy Pregnancies Re-Purposed to Target Tumors: Novel Checkpoint Inhibition in Cancer TherapeuticsElizabeth Ann L Enninga, Wendy K Nevala, Shernan G Holtan, et al.
Pageof 15